Clinical Trials Browser

Phase 3 × Multiple Endocrine Neoplasia Type 1 × Clear all

Cystitis, Prostatitis, Urinary Tract Infections, Multiple Endocrine Neoplasia Type 1

NCT03872401 2025-11-10

VESALIUS-CV

Phase 3 Completed

12,301 enrolled

Endocrine

Coronary Disease, Multiple Endocrine Neoplasia Type 1

NCT02437318 2025-02-13

SOLAR-1

Phase 3 Completed

572 enrolled 22 charts 1 FDA

BreastEndocrine

Breast Neoplasms, Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT02422615 2023-11-30

MONALEESA-3

Phase 3 Completed

726 enrolled 17 charts 1 FDA

BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

NCT03050398 2020-05-28

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase 3 Terminated

8 enrolled 4 charts

BreastEndocrine

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT02358226 2020-02-17

HIV & Drug Abuse Prevention for South African Men

Phase 3 Completed

1,211 enrolled

Endocrine

Acquired Immunodeficiency Syndrome, Alcoholism, Multiple Endocrine Neoplasia Type 1, Substance-Related Disorders

NCT00980174 2018-10-17

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Phase 3 Completed

242 enrolled 19 charts

Endocrine

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

NCT00314028 2013-12-16

Effectiveness of HIV Risk Reduction Program Among African American Men

Phase 3 Completed

270 enrolled

Endocrine

Sexually Transmitted Diseases, Multiple Endocrine Neoplasia Type 1

NCT00767338 2013-07-02

VIA

Phase 3 Terminated

3 enrolled 3 charts

Endocrine

Infertility, Multiple Endocrine Neoplasia Type 1

Clinical Trials

FOMUTI

VESALIUS-CV

SOLAR-1

MONALEESA-3

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

HIV & Drug Abuse Prevention for South African Men

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Effectiveness of HIV Risk Reduction Program Among African American Men

VIA